Simplex Trading, LLC Aclaris Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

A detailed history of Simplex Trading, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 6,695 shares of ACRS stock, worth $8,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,695

Previous 1,085 517.05%

Holding current value

$8,569

Previous $1,000 1500.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$1.15 - $4.59 $6,451 - $25,749	5,610 Added 517.05%	6,695 $16,000
Q3 2024 Nov 08, 2024	SELL	$1.12 - $1.4 $10,170 - $12,713	-9,081 Reduced 89.33%	1,085 $1,000
Q2 2024 Jul 25, 2024	SELL	$1.01 - $1.36 $18,076 - $24,341	-17,898 Reduced 63.78%	10,166 $11,000
Q1 2024 Apr 25, 2024	BUY	$0.92 - $1.44 $25,818 - $40,412	28,064 New	28,064 $34,000
Q3 2023 Nov 01, 2023	BUY	$6.56 - $10.95 $177,651 - $296,536	27,081 Added 1155.83%	29,424 $201,000
Q2 2023 Aug 04, 2023	SELL	$7.89 - $10.64 $972,710 - $1.31 Million	-123,284 Reduced 98.13%	2,343 $24,000
Q1 2023 Apr 27, 2023	BUY	$7.07 - $17.95 $887,525 - $2.25 Million	125,534 Added 134982.8%	125,627 $1.02 Million
Q4 2022 Feb 02, 2023	SELL	$14.33 - $18.37 $12,596 - $16,147	-879 Reduced 90.43%	93 $1,000
Q3 2022 Nov 04, 2022	BUY	$13.07 - $18.22 $12,704 - $17,709	972 New	972 $15,000
Q2 2022 Aug 03, 2022	SELL	$10.16 - $17.08 $126,817 - $213,192	-12,482 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$9.74 - $17.92 $114,123 - $209,968	-11,717 Reduced 48.42%	12,482 $215,000
Q4 2021 Feb 23, 2022	BUY	$12.27 - $18.49 $244,860 - $368,986	19,956 Added 470.33%	24,199 $351,000
Q3 2021 Oct 28, 2021	SELL	$13.38 - $18.8 $3,960 - $5,564	-296 Reduced 6.52%	4,243 $73,000
Q2 2021 Aug 12, 2021	SELL	$17.08 - $29.6 $161,132 - $279,246	-9,434 Reduced 67.52%	4,539 $79,000
Q1 2021 Apr 26, 2021	BUY	$5.86 - $27.73 $59,045 - $279,407	10,076 Added 258.56%	13,973 $352,000
Q4 2020 Feb 02, 2021	BUY	$2.65 - $7.61 $1,857 - $5,334	701 Added 21.93%	3,897 $25,000
Q3 2020 Oct 14, 2020	BUY	$1.5 - $2.71 $4,021 - $7,265	2,681 Added 520.58%	3,196 $8,000
Q2 2020 Jul 13, 2020	BUY	$1.04 - $1.73 $535 - $890	515 New	515 $0
Q1 2020 Apr 29, 2020	SELL	$0.75 - $2.18 $189 - $549	-252 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$1.02 - $1.97 $1,695 - $3,274	-1,662 Reduced 86.83%	252 $0
Q3 2019 Oct 15, 2019	SELL	$0.79 - $2.47 $2,159 - $6,752	-2,734 Reduced 58.82%	1,914 $2,000
Q2 2019 Jul 26, 2019	BUY	$2.13 - $7.06 $5,618 - $18,624	2,638 Added 131.24%	4,648 $10,000
Q1 2019 Apr 18, 2019	BUY	$5.63 - $7.84 $9,233 - $12,857	1,640 Added 443.24%	2,010 $0
Q4 2018 Jan 16, 2019	BUY	$6.3 - $15.4 $2,331 - $5,698	370 New	370 $2,000

Others Institutions Holding ACRS

# of Institutions

107

Shares Held

87.8M

Call Options Held

293K

Put Options Held

124K

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $85.3M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Aclaris Therapeutics, Inc. Transaction History